top of page
Executive Spotlights

SERB Pharmaceuticals names Vanessa Wolfeler as CEO

Philadelphia, PA, May 30, 2024 (Globe Newswire) -- Vanessa Wolfeler will take over as CEO of SERB Pharmaceuticals on June 3, 2024. Outgoing CEO Anthony Higham will assist with the transition through the end of the year. Higham will then serve as an advisor to the board from 2025.

Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e


Life Science Headlines
bottom of page